Health
Ethical decisions: Weighing risks and benefits of approving COVID-19 vaccination in children ages 5-11 – The Conversation CA
When making the decision whether to vaccinate children aged five to 11 against COVID-19, regulators in Canada must rely on sound…
The U.S. Food and Drug Administration has approved Pfizers COVID-19 vaccine for use in children ages five to 11. Pfizers clinical trial results indicate the vaccine is safe and effective in this age group.
This is an important development. COVID-19 infectionsare…
Continue Reading
-
Noosa News14 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
Noosa News18 hours ago’Lethal new opioids’ prompt Wide Bay pill testing call
-
Business15 hours ago10 ASX shares to buy after the market selloff
-
General19 hours ago‘We are here for you’: PM to bring help to flood zones